Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations
Abstract Background Multiple daily subcutaneous injections (MDSIs) are mainly used for formulating an insulin therapy for diabetic patients; however, they also cause insulin-derived amyloidosis (IDA) and lead to poor glycemic control. In addition, for the continuous subcutaneous insulin infusion sys...
Furkejuvvon:
Váldodahkkit: | Yui Ohno (Dahkki), Tomohiro Seki (Dahkki), Yu Kojima (Dahkki), Ryotaro Miki (Dahkki), Yuya Egawa (Dahkki), Osamu Hosoya (Dahkki), Keizo Kasono (Dahkki), Toshinobu Seki (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
BMC,
2019-10-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Cell Adhesive Character of Phenylboronic Acid-Modified Insulin and Its Potential as Long-Acting Insulin
Dahkki: Yui Ohno, et al.
Almmustuhtton: (2019) -
Icariin Attenuates Amyloid-β (Aβ)-Induced Neuronal Insulin Resistance Through PTEN Downregulation
Dahkki: Xiaomei Zou, et al.
Almmustuhtton: (2020) -
Improved Dissolution Behavior of Dipyridamole Formulation with Precipitation Inhibitor
Dahkki: Maryam Maghsoodi, et al.
Almmustuhtton: (2020) -
Activation of Insulin Receptors by Lagerstroemin
Dahkki: Katsuji Hattori, et al.
Almmustuhtton: (2003) -
Concentrated insulins: the new basal insulins
Dahkki: Lamos EM, et al.
Almmustuhtton: (2016)